Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study

Date
2021
Author
Okumus, Gulfer
Baygul, Arzu
SAYIN, TAMER
ÖNEN, ZEYNEP PINAR
Yokusoglu, Mehmet
Kucukoglu, Mehmet Serdar
HANTA, İSMAİL
AKDENİZ, BAHRİ
Gullulu, Sumeyye
Atahan, Ersan
Metadata
Show full item record
Abstract
Objective: To evaluate clinical efficacy, safety and tolerability of long-term inhaled iloprost treatment in the daily practice for the management of pulmonary arterial hypertension (PAH).
URI
http://hdl.handle.net/20.500.12627/169044
https://doi.org/10.5152/anatoljcardiol.2021.03009
Collections